MiNK Therapeutics (6Q40.F) Q2 2026 Earnings

May 15Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.91
-0.76
-0.62
-0.47

Details

Expected EPS
-0.6623463
Actual EPS
-0.4903083
Surprise EPS
0.17
Surprise Percent
+25.97%

Description

⁨MiNK Therapeutics⁩ (⁦6Q40.F⁩) has reported earnings of ⁦-0.4903083⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts